ERBB2 and breast cancer: Building upon our discoveries, it is prudent to postulate that t an increase in the 13(S)-HODE content in a linoleic acid-rich diet, may lead to poor anti-HER2 treatment outcomes in HER2-positive breast cancer patients, and this effect is mediated through its promotion of PPARG activity, contributing to resistance.